Arian Resources Corp.

Healthcare CA ARC

0.01CAD
0.00(0%)

Last update at 2026-06-23T13:44:00Z

Day Range

0.010.01

LowHigh

52 Week Range

0.010.10

LowHigh

Fundamentals

Previous Close 0.01
Market Cap1.28M
Volume1000
P/E Ratio-
Dividend Yield-%
EBITDA-2.12572M
Revenue TTM0.61M
Revenue Per Share TTM0.005
Gross Profit TTM 0.51M
Diluted EPS TTM-0.03

Overview
Financials
Peer Comparison
Reports
Stock Research & News
Profile

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Income before tax	-2.10508M	1.13M	-9.14533M	-8.32066M	5.72M
Minority interest	-0.01075M	0.00935M	0.28M	0.28M	0.01M
Net income	-2.11583M	1.36M	-8.66342M	-8.04074M	5.73M
Selling general administrative	2.38M	6.05M	8.03M	9.14M	6.61M
Selling and marketing expenses	-	-	-	-	-
Gross profit	0.51M	3.40M	1.79M	5.91M	12.91M
Reconciled depreciation	0.47M	0.58M	0.72M	0.28M	0.11M
Ebit	-	-	-	-	-
Ebitda	-	-	-	-	-
Depreciation and amortization	-	-	-	-	-
Non operating income net other	-	-	-	-	-
Operating income	-2.57317M	-3.78784M	-7.57448M	-3.87890M	5.80M
Other operating expenses	-	-	-	-	-
Interest expense	0.64M	0.83M	0.74M	0.71M	0.19M
Tax provision	0.00000M	-0.21605M	-0.20516M	0.00000M	-
Interest income	-	-	-	-	-
Net interest income	-0.64398M	-0.82959M	-0.73524M	-0.70732M	-0.19241M
Extraordinary items	-	-	-	-	-
Non recurring	-	-	-	-	-
Other items	-	-	-	-	-
Income tax expense	-	-	-	-	-
Total revenue	0.61M	5.51M	6.67M	10.88M	19.15M
Total operating expenses	3.18M	9.29M	14.24M	14.76M	13.35M
Cost of revenue	0.10M	2.11M	4.88M	4.98M	6.24M
Total other income expense net	1.11M	5.75M	-0.83561M	-3.73445M	0.11M
Discontinued operations	-	-	-	-	-
Net income from continuing ops	-2.10508M	1.35M	-8.94017M	-8.32066M	5.72M
Net income applicable to common shares	-	-	-	-	-
Preferred stock and other adjustments	-	-	-	-	-

Breakdown	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total assets	3.04M	3.26M	6.75M	15.12M	14.18M
Intangible assets	0.05M	0.43M	0.80M	1.18M	0.13M
Earning assets	-	-	-	-	-
Other current assets	-	-	0.53M	0.54M	0.47M
Total liab	10.84M	9.82M	17.14M	16.51M	16.99M
Total stockholder equity	-7.74566M	-6.47386M	-10.30954M	-1.58903M	-2.81030M
Deferred long term liab	-	-	-	-	-
Other current liab	-	-	-	-	-
Common stock	-	-	-	-	-
Capital stock	11.37M	10.86M	8.99M	8.75M	0.68M
Retained earnings	-20.95539M	-18.83956M	-20.19747M	-11.53406M	-3.49331M
Other liab	-	-	-	-	-
Good will	-	0.00000M	0.00000M	0.44M	-
Other assets	-	-	-	-	-
Cash	0.00494M	0.08M	0.92M	6.00M	4.97M
Cash and equivalents	-	-	-	-	-
Total current liabilities	9.39M	8.56M	7.31M	4.96M	4.43M
Current deferred revenue	-	-	-	-	-
Net debt	8.48M	7.37M	6.08M	0.73M	1.39M
Short term debt	-	-	-	-	-
Short long term debt	7.04M	6.26M	4.38M	2.56M	-
Short long term debt total	-	-	-	-	-
Other stockholder equity	-	-	-	-	-
Property plant equipment	-	-	-	-	-
Total current assets	0.44M	0.74M	2.91M	9.25M	10.99M
Long term investments	2.37M	1.68M	0.00000M	-	-
Net tangible assets	-	-	-	-	-
Short term investments	-	-	-	-	-
Net receivables	0.31M	0.50M	0.79M	1.08M	2.99M
Long term debt	1.44M	1.18M	2.62M	4.17M	6.35M
Inventory	-	0.00000M	0.06M	0.16M	0.31M
Accounts payable	2.02M	1.85M	0.90M	0.42M	0.70M
Total permanent equity	-	-	-	-	-
Noncontrolling interest in consolidated entity	-	-	-	-	-
Temporary equity redeemable noncontrolling interests	-	-	-	-	-
Accumulated other comprehensive income	-	-	-	-	-
Additional paid in capital	-	-	-	-	-
Common stock total equity	-	-	-	-	-
Preferred stock total equity	-	-	-	-	-
Retained earnings total equity	-	-	-	-	-
Treasury stock	-	-	-	-	-
Accumulated amortization	-	-	-	-	-
Non currrent assets other	-	-	1.98M	2.56M	2.05M
Deferred long term asset charges	-	-	-	-	-
Non current assets total	2.60M	2.51M	3.84M	5.87M	3.19M
Capital lease obligations	0.03M	0.16M	0.79M	1.34M	0.98M
Long term debt total	-	-	-	-	-

Breakdown	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Investments	-	0.05M	-0.33164M	1.73M	-0.77074M
Change to liabilities	-	-	-	-	-
Total cashflows from investing activities	-	-	-	-	-
Net borrowings	0.31M	-	-	-	-
Total cash from financing activities	0.85M	1.77M	-0.60356M	-0.55936M	-1.57971M
Change to operating activities	-	-	-	-	-
Net income	-2.11583M	1.36M	-8.66342M	-8.04074M	5.73M
Change in cash	-0.07218M	-0.83959M	-5.08691M	1.04M	2.84M
Begin period cash flow	0.08M	0.92M	6.00M	4.97M	2.13M
End period cash flow	0.00494M	0.08M	0.92M	6.00M	4.97M
Total cash from operating activities	-1.28366M	-2.59272M	-4.20279M	-0.13168M	5.19M
Issuance of capital stock	0.54M	1.76M	0.00000M	1.58M	0.00000M
Depreciation	0.47M	0.58M	0.72M	0.28M	0.11M
Other cashflows from investing activities	-	-	-	-	-
Dividends paid	0.00000M	0.00000M	0.00000M	1.54M	1.74M
Change to inventory	-	0.00000M	0.01M	-0.39327M	-0.19925M
Change to account receivables	0.21M	-0.34110M	-0.04286M	2.14M	0.76M
Sale purchase of stock	-	-	0.00000M	-0.15000M	-2.65174M
Other cashflows from financing activities	-	-	-	-	-
Change to netincome	-	-	-	-	-
Capital expenditures	0.00000M	0.00000M	0.34M	1.52M	0.30M
Change receivables	-	-	-	-	-
Cash flows other operating	-	-	-	-	-
Exchange rate changes	-	-	-	-	-
Cash and cash equivalents changes	-	-	-	-	-
Change in working capital	0.38M	1.20M	2.81M	4.00M	-0.71000M
Stock based compensation	0.30M	0.46M	0.14M	0.98M	0.00310M
Other non cash items	0.64M	-0.27941M	-0.06032M	2.16M	-0.01284M
Free cash flow	-1.28366M	-2.59272M	-4.54221M	-1.65339M	4.89M

Peer Comparison

Sector: Healthcare Industry: Diagnostics & Research

Company	Change (CAD)	Price (CAD)	Trailing PE (x)	Forward PE (x)	Price Sales TTM (x)	Price to Book Value (x)	Enterprise Value to Revenue (x)	Enterprise Value to EBITDA (x)
ARC Arian Resources Corp.	- -%	0.01	-	-	2.12	-	15.59	2.25
JUMP Leveljump Healthcare Corp	- -%	0.06	3.50	-	0.36	1.00	0.82	8.59
AVCR Avricore Health Inc	- -%	0.06	-	-	3.16	5.09	3.30	41.13
TELO Telo Genomics Corp	- -%	0.04	-	-	-	8.78	-6.3236
MBI-H Med BioGene Inc	- -%	0.03	-	-	-	-	-3.032

Reports Covered

View All

Profile

ARCpoint Inc. provides franchise systems offering drug, alcohol, DNA, and clinical lab testing and screening services in the United States. It operates in two segments, ARCpoint Franchise and AFG Services. The company offers viral testing for viruses, such as Flu, Strep, and covid; regulatory compliance testing; ailments testing; preventive care services, including annual health, heart health, thyroid, diabetes, and hormone testing; nutritional testing comprising food allergy/sensitivity and vitamin/nutrient deficiency testing; and specialty health solutions such as TB and titer, pregnancy - related, respiratory/allergy, and blood type testing services, as well as vaccine, vitamin and supplements injections. It also provides drug, alcohol, and on-site mobile testing; paternity and DNA services; STD; and dry eyes testing services. In addition, the company offers employer solutions consisting of DOT solutions, background screening, HR employment solutions, and employee assistance programs. Further, it provides marketing, technology, and training services. The company provides services to individuals, companies, and legal and healthcare professionals. The company was formerly known as RSI International Systems Inc. ARCpoint Inc. was founded in 1998 and is headquartered in Greenville, South Carolina.

Arian Resources Corp.

101 North Main Street, Greenville, SC, United States, 29601

864 436 0018
https://www.arcpointlabs.com

Key Executives

Name	Title	Year Born
Mr. Adam Blaine Ho	Interim CFO, VP & Non Independent Chairman	NA
Mr. John Constantine	CEO, President & Non Independent Director	NA
Mr. Jason Tong C.A., C.F.A., CPA, CA, CFA	Controller	1984
Mr. Robert Mann	President of ARCpoint Franchise Group LLC	NA
Mr. Jason Tong C.A., C.F.A., CPA	Controller	1984

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.